Pharmacological and rAAV Gene Therapy Rescue of Visual Functions in a Blind Mouse Model of Leber Congenital Amaurosis
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Leber congenital amaurosis (LCA), a heterogeneous early-onset retinal dystrophy, accounts for approximately 15% of inherited congenital blindness. One cause of LCA is loss of the enzyme lecithin:retinol acyl transferase (LRAT), which is required for regeneration of the visual photopigment in the retina. METHODS AND FINDINGS: An animal model of LCA, the Lrat-/- mouse, recapitulates clinical features of the human disease. Here, we report that two interventions--intraocular gene therapy and oral pharmacologic treatment with novel retinoid compounds--each restore retinal function to Lrat-/- mice. Gene therapy using intraocular injection of recombinant adeno-associated virus carrying the Lrat gene successfully restored electroretinographic responses to approximately 50% of wild-type levels (p < 0.05 versus wild-type and knockout controls), and pupillary light responses (PLRs) of Lrat-/- mice increased approximately 2.5 log units (p < 0.05). Pharmacological intervention with orally administered pro-drugs 9-cis-retinyl acetate and 9-cis-retinyl succinate (which chemically bypass the LRAT-catalyzed step in chromophore regeneration) also caused long-lasting restoration of retinal function in LRAT-deficient mice and increased ERG response from approximately 5% of wild-type levels in Lrat-/- mice to approximately 50% of wild-type levels in treated Lrat-/- mice (p < 0.05 versus wild-type and knockout controls). The interventions produced markedly increased levels of visual pigment from undetectable levels to 600 pmoles per eye in retinoid treated mice, and approximately 1,000-fold improvements in PLR and electroretinogram sensitivity. The techniques were complementary when combined. CONCLUSION: Intraocular gene therapy and pharmacologic bypass provide highly effective and complementary means for restoring retinal function in this animal model of human hereditary blindness. These complementary methods offer hope of developing treatment to restore vision in humans with certain forms of hereditary congenital blindness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Retinoid Structures, Specificity of Retinoids in Regeneration of Visual Pigment, and Model of Absorption of 9-cis-R-Ac in Mammals (A) Structures of retinoids used for gavage studies. (B) Levels of all-trans-RAL oximes, 9-cis-RAL oximes (corresponding to formation of visual pigment isorhodopsin), and all-trans-REs in Lrat −/− mouse eyes gavaged with 5 mg of each retinoid before 48–72 h dark adaptation (n ≥ 3, data shown with standard deviation [SD]). (C) Model of absorption of 9-cis-R-Ac in mammals.](https://figures.cochat.ai/paper-figures/c3714af14746456fb8a9b714cfcb9e3f/pharmacological-and-raav-gene-therapy-rescue-of-visual-functions-in-a-blind-figure-1.jpg)



![Figure 5 Immunocytochemistry and ERG of rAAV-Lrat-Treated Lrat −/− Mice (A) Immunolocalization of LRAT (green) in rAAV-Lrat treated Lrat −/− mouse eye. Anti-LRAT antibody was directly labeled by Alexa 488. Expression of LRAT is locally restricted (arrowheads) in the eye. Nuclei are stained by Hoechst 33342 (blue). (B) Higher-power magnification image of (A). LRAT (green) is observed specifically in the RPE cell layer. (C) Subcellular localization of LRAT in rAAV-Lrat treated Lrat −/− mouse eye. RPE cells were labeled by anti-LRAT and detected by Cy3-labeled secondary antibody (red). Nuclei are stained by Hoechst 33342 (blue). RPE cell layer was mounted flat on a coverslip and imaged. LRAT is localized in the internal membrane of the RPE cells. Similar localization was observed for WT mouse RPE cells [12]. (D) Control flat-mounted RPE cell layer of untreated Lrat −/− mouse. Anti-LRAT antibody does not show any non-specific labeling. Bars indicate 100 μm. (E) Comparison of scotopic single flash ERG of rAAV-Lrat treated, Lrat +/+, and Lrat −/− control mice as measured by a-wave amplitudes, (n ≥ 16, data shown with SD). (F) A plot of a-wave amplitudes at 2.8 cd·s·m−2 intensity as a function of post-treatment time for rAAV-Lrat treated mice.](https://figures.cochat.ai/paper-figures/5be43b5f5c3a46c39f87286bb41ea53b/pharmacological-and-raav-gene-therapy-rescue-of-visual-functions-in-a-blind-figure-5.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast to other cell types, an overdose of all-trans-retinol does not result in excessive accumulation of retinyl esters in the RPE.567,575”
From Chemistry of the Retinoid (Visual) Cycle (2014) · cites this paper as [567]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Thus, blockage in production of 11-cis-retinal was overcome with oral delivery of another photosensitive but chemically more stable retinoid, 9-cis-retinal (Figure 36)567−571”
From Chemistry of the Retinoid (Visual) Cycle (2014) · cites this paper as [567]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A decade of molecular biology of retinoic acid receptors
Chambon, P. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.9.8801176 · Cited by 2,889 · cited 1×
“All-trans-RA and its 9-cis-isomer are important regulators of gene expression via nuclear receptors [52].”
Gene therapy restores vision in a canine model of childhood blindness
Acland, G. M., Aguirre, G. D., Ray, J., Zhang, Q., Aleman, T. S., Cideciyan, A. V., Pearce-Kelling, S. E., Anand, V., Zeng, Y., Maguire, A. M., et al. (2001) · Nature Genetics · doi:10.1038/ng0501-92 · Cited by 1,202 · cited 4×
“A recombinant adenoassociated virus (rAAV) carrying wild-type (WT) Rpe65 (rAAV-Rpe65) restored visual function in this model of childhood blindness [9].”
InfluentialSelf-citationRpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle
Redmond., T. M., Yu, S., Lee, E., Bok, D., Hamasaki, D., Chen, N., Goletz, P., Ma, J.-X., Crouch, R. K., & Pfeifer, K. (1998) · Nature Genetics · doi:10.1038/3813 · Cited by 929 · cited 1×
“Humans with this form of LCA and Rpe65 / mice both have severely impaired rod and cone function [6].”
Rod outer segment disk shedding in rat retina: relationship to cyclic lighting
LaVail, M. M. (1976) · Science · doi:10.1126/science.982063 · Cited by 689
A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells
Zolotukhin, S., Potter, M., Hauswirth, W. W., Guy, J., & Muzyczka, N. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4646-4654.1996 · Cited by 609 · cited 1×
“The pTR-UF5 backbone [13] was used for generation of a pTR-VMD2-mLRAT plasmid construct.”
Self-citationOrganization of the G Protein-coupled Receptors Rhodopsin and Opsin in Native Membranes
Liang, Y., Fotiadis, D., Filipek, S., Saperstein, D. A., Palczewski, K., & Engel, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302536200 · Cited by 596 · cited 1×
“These data are reminiscent of results obtained following gene therapy of RPE65-deficient mice and dogs [7,9,12,16,49,50].”
Self-citationStrange vision: ganglion cells as circadian photoreceptors
Berson, D. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00130-9 · Cited by 546
Chemistry of Visual Adaptation in the Rat
DOWLING, J. E. (1960) · Nature · doi:10.1038/188114a0 · Cited by 543 · cited 1×
“rods were all consistent with bleaching adaptation produced by residual opsin activity in the absence of a chromophore [”
Protection of mouse photoreceptors by survival factors in retinal degenerations.
LaVail, M. M., Yasumura, D., Matthes, M. T., Lau-Villacorta, C., Unoki, K., Sung, C. –., & Steinberg, R. H. (1998) · PubMed · Cited by 537
Retinal remodeling triggered by photoreceptor degenerations
Jones, B. W., Watt, C. B., Frederick, J. M., Baehr, W., Chen, C., Levine, E. M., Milam, A. H., Lavail, M. M., & Marc, R. E. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10703 · Cited by 476 · cited 2×
“While full restitution of the ERG could not be obtained in Lrat / mice in the tested experimental conditions, our finding of nearly complete restitution of single cell responses suggests that remodeling of the neuronal retina in Lrat / may limit functional rescue [35].”
Self-citation
Research works printed but not linked: 6
- Acland, 2001, Nat Genet, 28, 92
- Klvanova, 2002, Endocr Regul, 36, 133
- Bok, 1985, Invest Ophthalmol Vis Sci, 26, 1659
- LaVail, 1998, Invest Ophthalmol Vis Sci, 39, 592
- Naash, 1989, Prog Clin Biol Res, 314, 513
- Baylor, 1987, Invest Ophthalmol Vis Sci, 28, 34
Cited by
Phagocytosis of Retinal Rod and Cone Photoreceptors
Kevany, B. M., & Palczewski, K. (2010) · Physiology · doi:10.1152/physiol.00038.2009 · Cited by 426
“In contrast, unspent chromophore 11-cisretinal is re-used and sent back to OS (4).”
Self-citationDiseases Caused by Defects in the Visual Cycle: Retinoids as Potential Therapeutic Agents
Travis, G. H., Golczak, M., Moise, A. R., & Palczewski, K. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105225 · Cited by 419
“More recently, lrat−/− knockout mice were treated with recombinant AAV carrying a WT mouse lrat cDNA (155).”
Self-citationChemistry of the Retinoid (Visual) Cycle
Kiser, P. D., Golczak, M., & Palczewski, K. (2014) · Chemical Reviews · doi:10.1021/cr400107q · Cited by 353
Self-citationBenoit, S. C., Kemp, C. J., Elias, C. F., Abplanalp, W., Herman, J. P., Migrenne, S., Lefevre, A.-L., Cruciani-Guglielmacci, C., Magnan, C., Yu, F., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36714 · Cited by 351
Chemistry and Biology of Vision
Palczewski, K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r111.301150 · Cited by 289
Self-citation
Metadata
- Authors
- Batten, M. L., Imanishi, Y., Tu, D. C., Doan, T., Zhu, L., Pang, J., Glushakova, L., Moise, A. R., Baehr, W., Van Gelder, R. N., Hauswirth, W. W., Rieke, F., & Palczewski, K.
- Affiliations
- University of Washington (US)
- Washington University in St. Louis (US)
- University of Florida (US)
- University of Utah (US)
- Corresponding author
- Palczewski, Krzysztof
- ORCID
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2005-11-01
- Volume
- 2
- Issue
- 11
- Pages
- e333
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC1274279
- OpenAlex
- W2108100103
- Cited by
- 134
- References
- 55
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 2 · 2022: 4 · 2021: 6 · 2020: 6 · 2019: 4 · 2018: 4 · 2017: 1 · 2016: 7 · 2015: 7 · 2014: 6 · 2013: 6 · 2012: 13
- FWCI
- 3.53
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- KU ScholarWorks (The University of Kansas) (submittedVersion, other-oa)
- Funders
- Foundation Fighting Blindness
- Research to Prevent Blindness
- University of Utah
- National Institutes of Health (EY-01730, EY09339)
- National Eye Institute (EY 13729, EY-01730, U10EY013729, R01EY008123, EY 09339, R01EY014988, EY 08123, R01EY011123, EY-11123, EY14988, R01EY009339, P30EY001730)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- Leber congenital amaurosis, LRAT, retinal dystrophy, chromophore regeneration, visual pigments, electroretinogram, pupillary light reflex, hereditary blindness
- MeSH terms
- Retinyl Esters, Acyltransferases, Adenoviridae, Administration, Oral, Animals, Blindness, Disease Models, Animal, Diterpenes, Genetic Vectors, Molecular Sequence Data, Prodrugs, Pupil, Retinal Pigments, Vitamin A, Genetic Therapy, Mice, Knockout, Optic Atrophy, Hereditary, Leber, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacological and rAAV Gene Therapy Rescue of Visual Functions in a Blind Mouse Model of Leber Congenital Amaurosis. https://app.cochat.ai/papers/10.1371/journal.pmed.0020333
- The paper
- Batten, M. L., Imanishi, Y., Tu, D. C., Doan, T., Zhu, L., Pang, J., Glushakova, L., Moise, A. R., Baehr, W., Van Gelder, R. N., Hauswirth, W. W., Rieke, F., & Palczewski, K. (2005). Pharmacological and rAAV Gene Therapy Rescue of Visual Functions in a Blind Mouse Model of Leber Congenital Amaurosis. PLoS Medicine. https://doi.org/10.1371/journal.pmed.0020333
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.